Optimizing Adult Pneumococcal Vaccination with PCV20

This presentation provides a comprehensive overview of pneumococcal disease and the critical role of vaccination, especially among vulnerable populations. It covers the pathogen S. pneumoniae, vaccine evolution, and serotype coverage, emphasizing differences in immune response between polysaccharide and conjugate vaccines. Key insights include updates from NACI, BC/BCCDC's adoption of Prevnar-20 starting July 2025, and clinical evidence supporting vaccine recommendations. Trials comparing...